ALPINE IMMUNE SCIENCES, INC. Lessee, Operating Lease, Liability, to be Paid
ALPINE IMMUNE SCIENCES, INC. had Lessee, Operating Lease, Liability, to be Paid of $13.77 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2024-03-20
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $13.77M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $15.83M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $17.84M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid $20.00M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-12-31 | $13.77M 10-K · filed 2024-03-20 |
| 2022-12-31 | $15.83M 10-K · filed 2023-03-23 |
| 2021-12-31 | $17.84M 10-K · filed 2022-03-17 |
| 2020-12-31 | $20.00M 10-K · filed 2021-03-18 |
| 2019-12-31 | $20.24M 10-K · filed 2020-03-30 |
| 2019-09-30 | $20.46M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $20.85M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $687.00K 10-Q · filed 2019-05-09 |